| Description |
1 online resource : illustrations |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Cancer etiology, diagnosis, and treatments |
|
Cancer etiology, diagnosis, and treatments.
|
| Bibliography |
Includes bibliographical references and index. |
| Note |
Print version record. |
| Contents |
ENCYCLOPEDIA OF CANCER TREATMENT; ENCYCLOPEDIA OF CANCER TREATMENT; Contents ; Preface; Micro-and Nano-Particulate Drug Delivery Systems for Cancer Treatment ; Abstract ; I. Introduction; II. Polymeric Particles ; II. 1. Poly (Alkylcyanoacrylate) ; II. 2. Chitosan ; II. 3. Poly ( -caprolactone) ; II. 4. Poly (D, L-lactide-co-glycolide) (PLGA) ; III. Vesicular Systems ; IV. Solid Lipid Nanoparticles ; V. Squalenoyl Nanomedicines; VI. Passive Targeting to Tumors ; VII. Active Targeting to Tumors; VII. 1. Ligand-mediated Targeting ; VII. 2. Stimuli-sensitive Carriers ; VIII. Oral Chemotherapy. |
|
IX. Drug Delivery to Brain Tumors X. Approaches for Overcoming Multi-Drug Resistance (MDR) ; Conclusion; References ; Geldanamycin Derivatives as Promising Anticancer Drugs: Therapy via Hsp90 Inhibition ; Abstract ; Introduction ; Hsp90: Essential Chaperone and Unique Target for Anticancer Therapy ; Geldanamycin and its Less Toxic Analogues as Anticancer Single Agents ; 17AAG and 17DMAG Can Sensitize Cancer Cells to other Chemotherapeutic Drugs; 17AAG and 17DMAG as Selective Radiosensitizers of Tumors ; 17AAG and 17DMAG Against Tumor Vasculature ; Problems and Perspectives; Conclusion. |
|
2. Abnormalization of Tumor 7Vasculature8. Synergistic Antitumor Activity of Metronomic Dosing of CPA n Combination with DXR-containing PEGylated Liposome ; 8.1. Hypothesis ; 8. 3. In an Experimental Murine Pulmonary Metastatic Tumor Model [102] ; 8.3.1. Experimental Condition: ; 8.3.2. Antitumor Effect by Combined Therapy ; 8.3. In an Experimental Murine Solid Tumor Model [103] ; 8.3.1. Experimental Condition: ; 8.3.2. Antitumor Effect of Combined Therapy ; Conclusion ; Acknowledgments ; References; Organotin Polyethers as Anticancer Drugs ; Abstract; Introduction ; Cell Line Studies. |
|
Molecular Level StudiesAdvantageous of Polymeric Drugs ; Organotin Polyethers- Synthesis ; Organotin Polyethers- Cell Line Results; Diethylstilbestrol Polymers; Alkane-Derived Polymers ; Butyne-Derived Polyethers ; Hydroquinone and Hydroquinone Derivatives ; Summary ; Future ; References ; Studies on Anti-Cancer Agents: Phenolic Compounds and their Pharmacological Activity ; Abstract ; Quercetin ; Silymarin ; Rutin ; Rosmarinic Acid ; Tea Flavonoids ; Hydroxytyrosol ; Ellagic Acid ; Apigenin ; Cosmociin and Narciclasine ; References. |
| Subject |
Cancer -- Treatment.
|
|
Cancer -- Traitement.
|
|
HEALTH & FITNESS -- Diseases -- Cancer.
|
|
MEDICAL -- Oncology.
|
|
Cancer -- Treatment
|
| Added Author |
Dunn, Timothy B., editor.
|
|
Holmes, Jennifer E., editor.
|
| Other Form: |
Print version: Encyclopedia of cancer treatment. [Hauppauge] New York : Nova Biomedical Books, [2012] 9781613244487 (DLC) 2012471878 (OCoLC)829445162 |
| ISBN |
9781624177958 (electronic bk.) |
|
1624177956 (electronic bk.) |
|
9781613244487 |
|
1613244487 |
|
